221 related articles for article (PubMed ID: 28697029)
1. Malignant Hyperthermia in a Morbidly Obese Patient Depletes Community Dantrolene Resources: A Case Report.
Magistris F; Gamble J
A A Case Rep; 2017 Nov; 9(9):251-253. PubMed ID: 28697029
[TBL] [Abstract][Full Text] [Related]
2. Mixing and using dantrolene for simulated malignant hyperthermia crisis.
Corvetto MA; Montaña R; Bravo MP; Altermatt FR
Acta Anaesthesiol Scand; 2012 Nov; 56(10):1337-8. PubMed ID: 22881345
[No Abstract] [Full Text] [Related]
3. Postoperative malignant hyperthermia confirmed by calcium-induced calcium release rate after breast cancer surgery, in which prompt recognition and immediate dantrolene administration were life-saving: a case report.
Miyazaki N; Kobayashi T; Komiya T; Okada T; Ishida Y; Fukui H; Ogihara Y; Uchino H
J Med Case Rep; 2021 Apr; 15(1):201. PubMed ID: 33863374
[TBL] [Abstract][Full Text] [Related]
4. Low-cost, easy-to-make simulated dantrolene for malignant hyperthermia scenarios.
Boet S
Acta Anaesthesiol Scand; 2014 Mar; 58(3):372-3. PubMed ID: 25237700
[No Abstract] [Full Text] [Related]
5. Rapid intervention for an episode of malignant hyperthermia.
Chartrand D
Can J Anaesth; 2003 Feb; 50(2):104-7. PubMed ID: 12560297
[No Abstract] [Full Text] [Related]
6. Upper extremity deep vein thrombosis in a patient treated for malignant hyperthermia.
Grodofsky S; Levitt C; Schlichter RA; Stanton DC; Liu R; Chen L
J Clin Anesth; 2013 Jun; 25(4):350-2. PubMed ID: 23707708
[No Abstract] [Full Text] [Related]
7. Comparison of the therapeutic effectiveness of a dantrolene sodium solution and a novel nanocrystalline suspension of dantrolene sodium in malignant hyperthermia normal and susceptible pigs.
Schütte JK; Becker S; Burmester S; Starosse A; Lenz D; Kröner L; Wappler F; Gerbershagen MU
Eur J Anaesthesiol; 2011 Apr; 28(4):256-64. PubMed ID: 21513076
[TBL] [Abstract][Full Text] [Related]
8. Availability of dantrolene for the management of malignant hyperthermia crises: European Malignant Hyperthermia Group guidelines.
Glahn KPE; Bendixen D; Girard T; Hopkins PM; Johannsen S; Rüffert H; Snoeck MM; Urwyler A;
Br J Anaesth; 2020 Aug; 125(2):133-140. PubMed ID: 32591088
[TBL] [Abstract][Full Text] [Related]
9. Malignant hyperthermia in a young adolescent: A case report.
Toh H; Shahani JM; Ali AJ
Natl Med J India; 2014; 27(5):259-60. PubMed ID: 26037425
[TBL] [Abstract][Full Text] [Related]
10. Ryanodex--A New Dantrolene Formulation for Malignant Hyperthermia.
Med Lett Drugs Ther; 2015 Jul; 57(1472):100. PubMed ID: 26147894
[No Abstract] [Full Text] [Related]
11. [Suspected case of postoperative malignant hyperthermia treated with dantrolene one week after neurosurgery].
Itoh K; Nishibe S; Usuda Y; Kitamura A
Masui; 2014 Oct; 63(10):1153-5. PubMed ID: 25693350
[TBL] [Abstract][Full Text] [Related]
12. Postoperative hyperthermia of unknown origin treated with dantrolene sodium.
Inada H; Jinno S; Kohase H; Fukayama H; Umino M
Anesth Prog; 2005; 52(1):21-3. PubMed ID: 15859445
[TBL] [Abstract][Full Text] [Related]
13. [Malignant hyperthermia].
Zimprich F; Kress HG; Zeitlhofer J
Wien Klin Wochenschr; 2003 Sep; 115(15-16):556-62. PubMed ID: 14531168
[TBL] [Abstract][Full Text] [Related]
14. Malignant hyperthermia in a liver transplant patient: a case report.
Fernandes CR; Azevedo DM; Gomes JM; Gonçalves BP; Coelho GR; Vasconcelos JB; Garcia JH
Transplant Proc; 2007 Dec; 39(10):3530-2. PubMed ID: 18089429
[TBL] [Abstract][Full Text] [Related]
15. Presumed Malignant Hyperthermia Treated During Cardiopulmonary Bypass in a Pediatric Patient Undergoing Aortic Valve Replacement: A Case Report.
Kuntz MT; Saab AD
A A Pract; 2019 Apr; 12(7):246-248. PubMed ID: 30299295
[TBL] [Abstract][Full Text] [Related]
16. Malignant hyperthermia.
Ben Abraham R; Adnet P; Glauber V; Perel A
Postgrad Med J; 1998 Jan; 74(867):11-7. PubMed ID: 9538480
[TBL] [Abstract][Full Text] [Related]
17. Secretion of dantrolene into breast milk after acute therapy of a suspected malignant hyperthermia crisis during cesarean section.
Fricker RM; Hoerauf KH; Drewe J; Kress HG
Anesthesiology; 1998 Oct; 89(4):1023-5. PubMed ID: 9778021
[No Abstract] [Full Text] [Related]
18. Prophylactic use of dantrolene in a patient with central core disease.
Michalek-Sauberer A; Gilly H
Anesth Analg; 1998 Apr; 86(4):915-6. PubMed ID: 9539627
[No Abstract] [Full Text] [Related]
19. Cost-benefit Analysis of Maintaining a Fully Stocked Malignant Hyperthermia Cart versus an Initial Dantrolene Treatment Dose for Maternity Units.
Ho PT; Carvalho B; Sun EC; Macario A; Riley ET
Anesthesiology; 2018 Aug; 129(2):249-259. PubMed ID: 29672336
[TBL] [Abstract][Full Text] [Related]
20. Malignant hyperthermia.
Heggie J
Can J Anaesth; 1999 Sep; 46(9):910. PubMed ID: 10490170
[No Abstract] [Full Text] [Related]
[Next] [New Search]
